Rockwell Medical (RMTI) Capital Expenditures (2010 - 2026)
Rockwell Medical (RMTI) posted Capital Expenditures of $425000.0 for Q1 2026, up 394.19% on a QoQ basis from $86000.0 in Q4 2025, and up 574.6% year-over-year from $63000.0 in Q1 2025.
Rockwell Medical (RMTI) Capital Expenditures (2010 - 2026) Analysis & Trends
Rockwell Medical's Capital Expenditures history runs 17 years deep, the most recent figure standing at $425000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 574.6% year-over-year to $425000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $904000.0 (down 3.32% YoY) and the FY2025 annual result came in at $542000.0, down 46.39% from the prior year.
- Capital Expenditures was $425000.0 for Q1 2026 at Rockwell Medical, up from $86000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $425000.0 in Q1 2026 and bottomed at -$80000.0 in Q3 2022.
- A 5-year average of $149588.2 and a median of $139000.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures sank 162.99% — and 2024, when it soared 1093.75%.
- Rockwell Medical's Capital Expenditures stood at $281000.0 in 2022, then tumbled by 84.7% to $43000.0 in 2023, then surged by 818.6% to $395000.0 in 2024, then sank by 78.23% to $86000.0 in 2025, then soared by 394.19% to $425000.0 in 2026.
- Business Quant data shows RMTI's Capital Expenditures at $425000.0 in Q1 2026, $86000.0 in Q4 2025, and $229000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 425,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 425,000.00 |
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Jun 30, 2025 | 164,000.00 |
| Jun 30, 2025 | 164,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Dec 31, 2024 | 395,000.00 |
| Dec 31, 2024 | 395,000.00 |
| Sep 30, 2024 | 191,000.00 |
| Sep 30, 2024 | 191,000.00 |
| Jun 30, 2024 | 286,000.00 |
| Jun 30, 2024 | 286,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |